Chemical activators of LONRF2 can have multifaceted roles in its functional activation through various biochemical pathways. Forskolin, a known direct stimulator of adenylyl cyclase, results in increased levels of cAMP within the cell. This surge in cAMP activates protein kinase A (PKA), which can phosphorylate LONRF2, thereby enhancing its activity. Similarly, Dibutyryl-cAMP and 8-Bromo-cAMP, both of which are cAMP analogs, also activate PKA, leading to the phosphorylation and subsequent activation of LONRF2. Another activator, Ionomycin, functions by increasing intracellular calcium levels, which can activate a cascade of calcium-dependent protein kinases with the potential to phosphorylate and activate LONRF2. The activation of LONRF2 by Phorbol 12-myristate 13-acetate (PMA) occurs through PMA's ability to directly activate protein kinase C (PKC), which is another kinase that can phosphorylate and thereby activate LONRF2.
In addition to these activators, Thapsigargin promotes the release of calcium from the endoplasmic reticulum by inhibiting SERCA, leading to the activation of calcium-dependent kinases that may target and activate LONRF2. Okadaic Acid and Calyculin A, both inhibitors of protein phosphatases PP1 and PP2A, result in a general increase in phosphorylation levels within the cell, which can include the phosphorylation and activation of LONRF2. Anisomycin activates stress-activated protein kinases, which in response to cellular stress conditions can phosphorylate and activate LONRF2. Epigallocatechin Gallate (EGCG), through its inhibition of phosphodiesterases, indirectly increases cAMP levels, thus promoting PKA activation and potential phosphorylation of LONRF2. Brefeldin A's disruption of protein trafficking can lead to stress kinase activation, which may also phosphorylate and activate LONRF2. Lastly, Piceatannol's inhibition of Syk kinase alters downstream kinase activity, which may lead to the activation of kinases capable of phosphorylating and activating LONRF2, showcasing the diverse mechanisms through which LONRF2 can be functionally activated by chemical means.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as an ionophore that selectively binds to and transports calcium ions across membranes. The influx of calcium can activate calcium-dependent protein kinases, which in turn may phosphorylate and activate LONRF2. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA directly activates protein kinase C (PKC), which can phosphorylate LONRF2, resulting in its functional activation. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels, which can activate calcium-dependent kinases that phosphorylate and activate LONRF2. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell. This inhibition can result in sustained phosphorylation and activation of LONRF2. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs), which can then phosphorylate and activate LONRF2 as part of the cell's response to stress. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits phosphodiesterases, which degrade cAMP. The consequent rise in cAMP levels can activate PKA, which may then phosphorylate and activate LONRF2. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a membrane-permeable cAMP analog that activates PKA. Activated PKA can phosphorylate and activate LONRF2. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases, particularly PP1 and PP2A, similar to okadaic acid, leading to increased phosphorylation within cells and potential activation of LONRF2. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts protein trafficking and can lead to the activation of stress kinases, which may phosphorylate and activate LONRF2. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a stable cAMP analog that activates PKA. PKA can then phosphorylate and contribute to the functional activation of LONRF2. | ||||||